Clinical course of breast cancer patients with complete pathologic primary tumor and axillary lymph node response to doxorubicin-based neoadjuvant chemotherapy.

Kuerer, H M; Newman, L A; Smith, T L; Ames, F C; Hunt, K K; Dhingra, K; Theriault, R L; Singh, G; Binkley, S M; Sneige, N; Buchholz, T A; Ross, M I; McNeese, M D; Buzdar, A U; Hortobagyi, G N; Singletary, S E

Kuerer, H M; Newman, L A; Smith, T L; Ames, F C; Hunt, K K; Dhingra, K; Theriault, R L; Singh, G; Binkley, S M; Sneige, N; Buchholz, T A; Ross, M I; McNeese, M D; Buzdar, A U; Hortobagyi, G N; Singletary, S E.

Affiliation

Kuerer HM; Department of Surgical Oncology, University of Texas M.D. Anderson Cancer Center, Houston 77030, USA.

J Clin Oncol ; 17(2): 460-9, 1999 Feb.

Article in En | MEDLINE | ID: mdl-10080586

Subject(s)

Antineoplastic Combined Chemotherapy Protocols/therapeutic use; Breast Neoplasms/drug therapy; Lymph Nodes/pathology; Axilla; Breast Neoplasms/pathology; Breast Neoplasms/surgery; Combined Modality Therapy; Female; Follow-Up Studies; Humans; Lymphatic Metastasis; Middle Aged; Neoadjuvant Therapy; Prospective Studies

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Antineoplastic Combined Chemotherapy Protocols / Lymph Nodes Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Female / Humans / Middle aged Language: En Journal: J Clin Oncol Year: 1999 Type: Article Affiliation country: United States

Search on Google

XML

PubMed Links